Literature DB >> 20488756

Coeliac disease autoantibodies mediate significant inhibition of tissue transglutaminase.

Greg Byrne1, Con Feighery, John Jackson, Jacinta Kelly.   

Abstract

The detection of antibodies directed against tissue transglutaminase (tTG) in serum is a sensitive and specific test for suspected coeliac disease. tTG is a ubiquitous, multifunctional enzyme that has been implicated in many important physiological processes as well as the site-specific deamidation of glutamine residues in gluten-derived peptides. This modification of gluten peptides facilitates their binding to HLA-DQ2, which results in amplification of the T-cell response to gluten. The purpose of this study was to investigate the possibility that patient IgA autoantibodies directed against tTG interfere with the crosslinking activity of the enzyme. IgA autoantibodies against tTG were isolated/depleted from patient serum and tested for their capacity to interfere with tTG activity in vitro using a sensitive fluorescence-based activity assay. We have demonstrated that autoantibodies cause significant inhibition of tTG-mediated crosslinking at equimolar and 2:1 ratios of antibody to enzyme. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488756     DOI: 10.1016/j.clim.2010.04.017

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  4 in total

Review 1.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

2.  Serine 129 Phosphorylation of α-Synuclein Cross-Links with Tissue Transglutaminase to Form Lewy Body-Like Inclusion Bodies.

Authors:  Wei Bi; Guohua Zhang; Yuanlin Sun; Lihong Zhu; Chuanming Wang; Yanran Liang; Qiaoyun Shi; Enxiang Tao
Journal:  ISRN Neurol       Date:  2011-04-11

3.  Modeling of celiac disease immune response and the therapeutic effect of potential drugs.

Authors:  Oleg O Demin; Sergey V Smirnov; Victor V Sokolov; Lourdes Cucurull-Sanchez; Cesar Pichardo-Almarza; M Victoria Flores; Neil Benson; Oleg V Demin
Journal:  BMC Syst Biol       Date:  2013-07-05

Review 4.  Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.

Authors:  Tiina Rauhavirta; Minna Hietikko; Teea Salmi; Katri Lindfors
Journal:  Clin Rev Allergy Immunol       Date:  2019-08       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.